Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: NEOVAXSYN INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-07-01 to 2022-12-31
Current total value of award: $300000
Description: THE CONTRACTOR SHALL UTILIZE NANOPARTICLES TO DELIVER THE MPER-BASED IMMUNOGENS TO ELICIT BNABS AGAINST THE MPER OF HIV-1 GP41 TO DEVELOP A PROTECTIVE VACCINE AGAINST THE VIRUS.